{
  "primary": "CALPAIN",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 2,
  "support_summary": "ATXN3 is a substrate for proteolytic cleavage by calpains, which generates toxic, aggregation-prone fragments of the protein, especially the polyQ-expanded mutant form.",
  "functions": [
    {
      "function": "Proteolytic Cleavage of ATXN3",
      "arrow": "activates",
      "cellular_process": "Under conditions of elevated intracellular calcium, calcium-activated neutral proteases (calpains) cleave ATXN3. This proteolytic processing is a key event in the pathogenesis of Machado-Joseph disease (SCA3), as it generates toxic fragments from the polyglutamine-expanded mutant protein.",
      "effect_description": "Calpains cleave polyQ-expanded ATXN3 at specific sites, producing C-terminal fragments that contain the expanded polyglutamine tract. These fragments are more prone to aggregation and are more cytotoxic than the full-length protein, contributing significantly to the formation of neuronal inclusions and neurodegeneration.",
      "biological_consequence": [
        "Pathological conditions cause dysregulation of intracellular Ca2+ homeostasis → Calpain proteases are over-activated → Calpains cleave polyQ-expanded ATXN3 at specific sites (e.g., D208, S256) → Toxic C-terminal fragments containing the polyQ tract are generated → Fragments misfold, aggregate, and form neuronal inclusions → Neurotoxicity and progressive neurodegeneration."
      ],
      "specific_effects": [
        "Cleaves ATXN3 at primary sites D208 and S256.",
        "Generates aggregation-prone and cytotoxic C-terminal fragments from polyQ-expanded ATXN3.",
        "Contributes to the formation of neuronal inclusions."
      ],
      "evidence": [
        {
          "paper_title": "A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3",
          "journal": "Brain",
          "year": 2017,
          "relevant_quote": "We found that ataxin-3 is primarily cleaved at two sites, namely at amino acid positions D208 and S256 and mutating amino acids at both cleavage sites to tryptophan nearly abolished ataxin-3 fragmentation. Furthermore, analysis of calpain cleavage-derived fragments showed distinct aggregation propensities and toxicities of C-terminal polyglutamine-containing breakdown products.",
          "pmid": "28334907"
        },
        {
          "paper_title": "Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease",
          "journal": "Human Molecular Genetics",
          "year": 2014,
          "relevant_quote": "As calpain over- activation has been shown to contribute to mutant ataxin-3 proteolysis, translocation to the nucleus, inclusions formation and neurodegeneration, we investigated the potential role of calpain inhibition as a therapeutic strat- egy to alleviate MJD pathology... Oral administration of the calpain inhibitor BDA-410 decreased both fragments formation and full-length ataxin-3 levels, reduced aggregation of mutant ataxin-3 and prevented cell injury and striatal and cerebellar degeneration.",
          "pmid": "24817574"
        }
      ],
      "pathway": {
        "name": "Proteolysis",
        "canonical_name": "Proteostasis",
        "ontology_id": "GO:0006457",
        "ontology_source": "GO",
        "confidence": 0.8
      },
      "pmids": [
        "28334907",
        "24817574"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "primary_to_main",
      "function_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "_chain_inferred": true,
  "is_valid": true,
  "mechanism_correction": "The input incorrectly describes the interaction as ATXN3 activating CALPAIN. The correct mechanism is the reverse: CALPAIN is a calcium-activated protease that cleaves ATXN3. ATXN3 is the substrate, not the activator.",
  "mechanism": "Under conditions of elevated intracellular calcium, calcium-activated neutral proteases (calpains) cleave ATXN3. This proteolytic processing is a key event in the pathogenesis of Machado-Joseph disease (SCA3), as it generates toxic fragments from the polyglutamine-expanded mutant protein.",
  "effect": "Calpains cleave polyQ-expanded ATXN3 at specific sites, producing C-terminal fragments that contain the expanded polyglutamine tract. These fragments are more prone to aggregation and are more cytotoxic than the full-length protein, contributing significantly to the formation of neuronal inclusions and neurodegeneration.",
  "summary": "ATXN3 activates CALPAIN to modulate proteolytic cleavage of atxn3, ultimately affecting neurotoxicity and progressive neurodegeneration.",
  "evidence": [
    {
      "paper_title": "A combinatorial approach to identify calpain cleavage sites in the Machado-Joseph disease protein ataxin-3",
      "journal": "Brain",
      "year": 2017,
      "relevant_quote": "We found that ataxin-3 is primarily cleaved at two sites, namely at amino acid positions D208 and S256 and mutating amino acids at both cleavage sites to tryptophan nearly abolished ataxin-3 fragmentation. Furthermore, analysis of calpain cleavage-derived fragments showed distinct aggregation propensities and toxicities of C-terminal polyglutamine-containing breakdown products."
    },
    {
      "paper_title": "Calpain inhibition reduces ataxin-3 cleavage alleviating neuropathology and motor impairments in mouse models of Machado-Joseph disease",
      "journal": "Human Molecular Genetics",
      "year": 2014,
      "relevant_quote": "As calpain over- activation has been shown to contribute to mutant ataxin-3 proteolysis, translocation to the nucleus, inclusions formation and neurodegeneration, we investigated the potential role of calpain inhibition as a therapeutic strat- egy to alleviate MJD pathology... Oral administration of the calpain inhibitor BDA-410 decreased both fragments formation and full-length ataxin-3 levels, reduced aggregation of mutant ataxin-3 and prevented cell injury and striatal and cerebellar degeneration."
    }
  ],
  "pathways": [
    {
      "name": "Proteolysis",
      "canonical_name": "Proteostasis",
      "ontology_id": "GO:0006457",
      "ontology_source": "GO",
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 4
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 <--regulates-- CALPAIN:",
  "protein_a": "ATXN3",
  "protein_b": "CALPAIN",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-11-30T15:37:50.127299Z",
  "last_updated": "2025-11-30T15:37:50.127299Z"
}